UBS Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Buy
447,991
+150,763
+51% +$4.94M ﹤0.01% 3109
2025
Q4
$11.1M Sell
297,228
-205,853
-41% -$6.77M ﹤0.01% 3172
2025
Q3
$13.9M Buy
503,081
+342,505
+213% +$11.8M ﹤0.01% 2952
2025
Q2
$5.07M Sell
160,576
-21,949
-12% -$706K ﹤0.01% 3862
2025
Q1
$6.06M Sell
182,525
-52,743
-22% -$1.89M ﹤0.01% 3589
2024
Q4
$8.1M Buy
235,268
+139,375
+145% +$4.79M ﹤0.01% 3295
2024
Q3
$3.84M Buy
95,893
+40,593
+73% +$1.43M ﹤0.01% 3354
2024
Q2
$1.67M Sell
55,300
-58,177
-51% -$1.75M ﹤0.01% 3954
2024
Q1
$3.81M Buy
113,477
+69,189
+156% +$2.22M ﹤0.01% 3262
2023
Q4
$1.43M Buy
44,288
+28,965
+189% +$808K ﹤0.01% 4166
2023
Q3
$502K Sell
15,323
-44,174
-74% -$1.53M ﹤0.01% 4649
2023
Q2
$2.09M Buy
59,497
+39,503
+198% +$1.36M ﹤0.01% 3473
2023
Q1
$653K Buy
19,994
+11,227
+128% +$511K ﹤0.01% 4486
2022
Q4
$483K Buy
8,767
+8,401
+2,295% +$462K ﹤0.01% 4743
2022
Q3
$16K Sell
366
-995
-73% -$48.5K ﹤0.01% 7685
2022
Q2
$66K Sell
1,361
-9,470
-87% -$426K ﹤0.01% 5719
2022
Q1
$527K Sell
10,831
-12,275
-53% -$501K ﹤0.01% 4650
2021
Q4
$986K Buy
23,106
+4,968
+27% +$198K ﹤0.01% 4407
2021
Q3
$695K Sell
18,138
-9,500
-34% -$306K ﹤0.01% 4492
2021
Q2
$781K Buy
27,638
+20,496
+287% +$615K ﹤0.01% 4387
2021
Q1
$236K Sell
7,142
-5,769
-45% -$202K ﹤0.01% 5363
2020
Q4
$467K Sell
12,911
-9,089
-41% -$367K ﹤0.01% 4658
2020
Q3
$746K Buy
+22,000
New +$802K ﹤0.01% 3859

Other funds holding HRMY